(lp0
S'The Insmed, Inc.  Receives $20.75 Average PT from Analysts Petro Global News 24 - Jan 29, 2017 Insmed, Inc.  has earned an average rating of Buy from the seven brokerages that are covering the company.'
p1
aS"The BlackRock Investment Management LLC Boosts Position in Insmed, Inc.  Petro Global News 24 - Feb 5, 2017 Palo Alto Investors LLC now owns 5,054,713 shares of the biopharmaceutical company's stock worth $49,839,000 after buying an additional 263,913 shares in the last quarter."
p2
aS'Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 ... GlobeNewswire  - Oct 5, 2016 BRIDGEWATER, N.J., Oct. 05, 2016  -- Insmed Incorporated , a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced a licensing agreement with AstraZeneca&nbsp;...'
p3
aS"Do Options Traders Know Something About Insmed Incorporated  Stock We Don't? Nasdaq - Mar 21, 2017 Clearly, options traders are pricing in a big move for Insmed Incorporated shares, but what is the fundamental picture for the company?Do Options Traders Know Something About Insmed Incorporated  Stock We ... - Zacks.com"
p4
aS"17.01 MarketWatch - Dec 21, 2009 Do Options Traders Know Something About Insmed Incorporated  Stock We Don't? Options traders are pricing in a big move for Insmed Incorporated  shares as it has huge implied volatility. Mar. 21, 2017 at 8:58 a.m. ET; on Zacks.com&nbsp;..."
p5
aS'Insmed Inc. INSM  Wall Street Journal - Feb 14, 2011 Lifshitz &amp; Miller Law Firm Announces Investigation of Calamos Asset Management, Inc., CDI Corp., comScore, Inc., Earthstone Energy, Inc., Heritage Oaks Bancorp, Insmed Incorporated, OCI Partners LP and Vascular Solutions, Inc. Press Release. load more.'
p6
aS'Insmed Incorporated and Transave, Inc. Announce Business Combination PR Newswire  - Dec 2, 2010 After giving effect to the merger, former Transave stockholders have approximately a 46.7% equity interest in the combined company , and Insmed Incorporated shareholders have a 53.3% interest on a fully diluted,&nbsp;...'
p7
aS"Why Insmed Incorporated Shares Skyrocketed Motley Fool - Jun 18, 2014 So what: According to Insmed's 8-K filing with the Securities and Exchange Commission prior to market open, the FDA granted Arikayce the breakthrough therapy designation for the treatment of adults with nontuberculous mycobacterial lung diseases that ...Insmed Soars on Arikayce's Breakthrough Designation - Zacks.com"
p8
aS'Technical Roundup On Two Stocks - Insmed Incorporated , First Interstate ... Post Analyst - 16 hours ago Insmed Incorporated has a consensus outperform rating from 7 Wall Street analysts, and the number of shares currently sold short amount to at least 6.94% of shares outstanding.'
p9
aS'Company Update : Insmed Incorporated Appoints Roger Adsett as ... Smarter Analyst - Sep 27, 2016 Insmed Incorporated  announced the appointment of Roger Adsett as chief commercial officer. Mr. Adsett was most recently senior vice president, head of the gastrointestinal and internal medicine business unit at Shire plc.'
p10
a.